| Company | Share, % |
|---|---|
Rocket Pharmaceuticals, Inc.
|
16.34 |
Orchestra BioMed Holdings, Inc.
|
14.71 |
GH Research PLC
|
10.65 |
Jounce Therapeutics, Inc.
|
9.7 |
Immunocore Holdings plc
|
9.66 |
Mirati Therapeutics, Inc.
|
9.65 |
PTC Therapeutics, Inc.
|
9.65 |
Cutera, Inc.
|
9.11 |
COMPASS Pathways plc
|
9.07 |
Stoke Therapeutics, Inc.
|
8.97 |
Establishment Labs Holdings Inc.
|
8.92 |
Taysha Gene Therapies, Inc.
|
8.89 |
Madrigal Pharmaceuticals, Inc.
|
8.78 |
Sage Therapeutics, Inc.
|
8.65 |
Replimune Group, Inc.
|
8.15 |
Oyster Point Pharma, Inc.
|
7.62 |
Exagen Inc.
|
7.49 |
Tarsus Pharmaceuticals, Inc.
|
7.33 |
uniQure
|
7.1 |
Akero Therapeutics, Inc.
|
6.85 |
| Category | Quantity |
|---|---|
| Healthcare | 33 |



















